Relation between cell-to-cell adhesion and angiogenesis and clinico-morphological prognostic factors in patients with gastric cancer

Experimental Oncology

Volumn 30, Issue 3, 2008, Pages 235-239

  Bazas, V M ^a   Lukyanova, N Yu ^b   Demash, D V ^b   Galakhin, K O ^c   Myasoedov, D V ^a  

^a SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Ukraine)

^b R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^c NATIONAL CANCER INSTITUTE   (Ukraine)

Author keywords

Alpha catenin; Beta catenin; E cadherin; Gastric cancer; Prognosis; VEGF

Indexed keywords

BETA CATENIN; MONOCLONAL ANTIBODY; UVOMORULIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER PATIENT; CANCER STAGING; CELL ADHESION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; STOMACH CANCER;

ALPHA CATENIN; BETA CATENIN; CADHERINS; CELL ADHESION; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 53649098312     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Catalano V, Labianca R, Beretta GD, et al. Gastric cancer. Cr Rev Oncol Hematol 2005;3: 209-41.
2. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A, The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002;8: 987-91.
3. Concolino P, Papa V, Mozzetti S, et al. The unsolved enigma of CDH1 down-regulation in hereditary diffuse gastric cancer. J Surg Res 2004;1: 50-5.
4. Dicken BJ, Bigam DL, Cass C, et al. Gastric adenocarcinoma. Review and considerations for future directions. Ann Surg 2005;1: 27-39.
5. Dumanskij YV, Vlasenko DL, Balashova OI, et al. Possibility of using HER-2/NEU & KI-67 as prognostic factors of distal stomach tumor answer for neoadjuvant therapy. Morphology 2008;2 (1): 51-6. (In Russian).
6. Ebert MPA, Yu J, Hoffmann J, et al. Loss of beta-catenin expression in metastatic gastric cancer. J Clin Oncol 2003;21: 1708-14.
7. EI-Rifai W, Powell SM, Molecular biology of gastric cancer. Sem Radiat Oncol 2002;2: 128-40.
8. Ferrara X, The role of VEGF in the regulation of physiological and pathological angiogenesis. Am J Physiol Cell Physiol 2001;280: 1358-66.
9. Fondevila C, Metges JP, Fuster J, et al. p53 and VEGF expression are independent predictors of tumor recurrence and survival following curative resection of gastric cancer. Br J Cancer 2004: 90: 206-15.
10. Graziano F, Humar B, Guilford P, The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol 2003;14: 1705-13.
11. Lakin GF, Biometry: manual forbiology specialized universities. Moscow: Vyschaya Shkola, 1990; 352 p. (In Russian).
12. Laurén P, The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64: 31-49.
13. Lieto E, Ferraraccio F, Orditura M, et al. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. Annals Surg Oncol 2008;15: 69-79.
14. Moriguchi K, Yamashita S, Tsujino Y, Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites. Cancer Lett 2007: 2: 178-87.
15. Nagashima F, Boku N, Ohtsu A, et al. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with irinotecan and cisplatin. JpnJ Clin Oncol 2005;35: 714-9.
16. Scott JA, Yap AS, Cinderella no longer: ct-catenin steps out of cadherin's shadow. J Cell Sci 2006;119: 4599-605.
17. Sobin LH, Wittekind C, eds. TNM classification of malignant tumours (5th ed.). New York, Chichester, Weinheim, Brisbane, Singapore, Toronto: Wiley-Liss, 1997. 285 p.
18. Stock M, Otto F, Gene deregulation in gastric cancer. Gene 2005;1: 1-19.
19. Vasylenko IV, Sadchinov VD, Galakhin KA, et al. Precancer and gastric cancer. Kyiv: Kniga plus, 2001; 232 p. (In Russian).
20. Wang L, Zhang F, Wu P-P. Disordered beta-catenin expression and E-cadherin/CDH 1 promoter methylation in gastric carcinoma. World J Gastroenterol 2006;12: 4228-31.
21. Weis WI, Nelson WJ, Re-solvingthe cadherin-cateninactin conundrum. J Biol Chem 2006;281: 35593-7.
22. Yasui W, Oue N, Aung PP, et al. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 2005;8: 86-94.